NL-OMON33378已完成不适用
Cell mediated immunity and the prediction of CMV disease in solid organ transplant recipients - CMI and CMV in organ transplantation
niversity of Alberta0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Adult CMV D+/R- liver transplant recipients
- •2. All eligible patients must be scheduled to receive 3 months of either valganciclovir, oral ganciclovir, or intravenous ganciclovir prophylaxis
排除标准
- •1. Scheduled to receive longer or shorter than 3-6 months of prophylaxis
- •2. Unable to provide informed consent
研究者
相似试验
已完成
不适用
Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant RecipientsTransplantNCT00436384University Health Network, Toronto150
已完成
不适用
Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant RecipientsCytomegalovirus ViraemiaNCT02784756University Health Network, Toronto134
已完成
不适用
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) PatientsCytomegalovirus InfectionNCT00699868Assistance Publique Hopitaux De Marseille29
已完成
不适用
Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT PatientsCytomegalovirus ViraemiaNCT02370758University Health Network, Toronto32
已完成
不适用
Acquired immune response to cytomegalovirus in corneal endotheliitiscorneal endotheliitisJPRN-UMIN000029494Tottori university Division of Ophthalmology and Visual Science50